[Special Stock] Hyronic Joins Dongwha Yakpum... Stock Price Surges Over 15%

Shares of Hironics, a beauty medical device company, are rising following news of its acquisition by Dongwha Pharm. Dongwha Pharm plans to actively enter the beauty medical device market through the acquisition of Hironics.

As of 9:20 a.m. on the 9th, Hironics was trading at 9,780 KRW, up 1,280 KRW (15.06%) from the previous trading day.

On the same day, Dongwha Pharm announced, "We signed a contract on the 6th to acquire 13,971,431 shares of Hironics for approximately 160.7 billion KRW." The total shares acquired include about 8.38 million existing shares and about 5.58 million new shares, resulting in Dongwha Pharm holding a 57.80% stake. The remaining payment and other procedures are expected to be completed by December 13, finalizing the transaction.

Dongwha Pharm explained the purpose of this contract as "securing new growth engines through entry into the beauty medical device market." Hironics was established in December 2007 and listed on the KOSDAQ market in December 2014. The company manufactures medical devices for hospital and clinic procedures, including high-intensity focused ultrasound (HIFU) product lines (Doublo, V-RO), Nd:YAG laser surgical devices, and general electrosurgical devices (SILKRO), as well as personal beauty devices (home care products).